Supplementary Table 1 - Gene Expression from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance

Supplementary Table 1 - Gene Expression from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance

<p>Gene Expression-RNAseq. Summary gene expression data of the individual tumors included in Fig. 5a-c.</p>

Сохранить в:

Библиографические подробности
Главный автор:	Renzo Perales-Linares (17314863) (author)
Другие авторы:	Nektaria Maria Leli (17314866) (author), Hesham Mohei (17314869) (author), Silvia Beghi (17314872) (author), Osvaldo D. Rivera (17314875) (author), Nektarios Kostopoulos (17314878) (author), Andrea Giglio (17314881) (author), Subin S. George (17314884) (author), Mireia Uribe-Herranz (17314887) (author), Francesca Costabile (17314890) (author), Stefano Pierini (17314893) (author), Sergei Pustylnikov (17314896) (author), Giorgos Skoufos (14865857) (author), Yoseph Barash (15130157) (author), Artemis G. Hatzigeorgiou (17314899) (author), Constantinos Koumenis (14865905) (author), Amit Maity (17314902) (author), Michael T. Lotze (14937723) (author), Andrea Facciabene (17314905) (author)
Опубликовано:	2025
Предметы:	Cancer Tumor Biology Immuno-oncology Immunology Tumor resistance to immune response Immunotherapy Combination immunotherapy Progression, Invasion & Metastasis Tumor progression
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Схожие документы

Supp. Figure 1 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
по: Renzo Perales-Linares (17314863)
Опубликовано: (2025)

Supp. Figure 2 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
по: Renzo Perales-Linares (17314863)
Опубликовано: (2025)

Supp. Figure 3 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
по: Renzo Perales-Linares (17314863)
Опубликовано: (2025)

Supp. Figure 4 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
по: Renzo Perales-Linares (17314863)
Опубликовано: (2025)

Supp. Figure 5 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
по: Renzo Perales-Linares (17314863)
Опубликовано: (2025)

Supp. Figure 6 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
по: Renzo Perales-Linares (17314863)
Опубликовано: (2025)

Figure S1 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
по: Xiaodong Shu (16721586)
Опубликовано: (2025)

Figure S2 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
по: Xiaodong Shu (16721586)
Опубликовано: (2025)

Figure S3 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
по: Xiaodong Shu (16721586)
Опубликовано: (2025)

Figure S4 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
по: Xiaodong Shu (16721586)
Опубликовано: (2025)

Figure S5 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
по: Xiaodong Shu (16721586)
Опубликовано: (2025)

Figure S6 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
по: Xiaodong Shu (16721586)
Опубликовано: (2025)

Figure S7 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
по: Xiaodong Shu (16721586)
Опубликовано: (2025)

Table S1-S9 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
по: Xiaodong Shu (16721586)
Опубликовано: (2025)

Supplementary Tables S2-13 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
по: Francisco Hermida-Prado (14958909)
Опубликовано: (2025)

Supplementary Tables from MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory Macrophages
по: Renumathy Dhanasekaran (14962092)
Опубликовано: (2025)

Supplementary Table1 from USP48 Stabilizes Gasdermin E to Promote Pyroptosis in Cancer
по: Yidan Ren (14845140)
Опубликовано: (2025)

Supplementary Table2 from USP48 Stabilizes Gasdermin E to Promote Pyroptosis in Cancer
по: Yidan Ren (14845140)
Опубликовано: (2025)

Supplementary Table3 from USP48 Stabilizes Gasdermin E to Promote Pyroptosis in Cancer
по: Yidan Ren (14845140)
Опубликовано: (2025)

Supplementary Table 7_Genes identified by differential expression analysis in pro vs non metastatic clones from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
по: Niccolò Roda (16437288)
Опубликовано: (2025)

Figure S.1 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
по: Xufeng Lu (14960724)
Опубликовано: (2025)

Figure S.2 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
по: Xufeng Lu (14960724)
Опубликовано: (2025)

Figure S.3 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
по: Xufeng Lu (14960724)
Опубликовано: (2025)

Figure S.4 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
по: Xufeng Lu (14960724)
Опубликовано: (2025)

Figure S.5 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
по: Xufeng Lu (14960724)
Опубликовано: (2025)

Figure S.6 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
по: Xufeng Lu (14960724)
Опубликовано: (2025)

Figure S.7 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
по: Xufeng Lu (14960724)
Опубликовано: (2025)

Figure S.8 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
по: Xufeng Lu (14960724)
Опубликовано: (2025)

Supplementary Table 6_Gene modules analysis_GO and curated pathways associated to gene modules from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
по: Niccolò Roda (16437288)
Опубликовано: (2025)

Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma
по: Isha Mondal (16721699)
Опубликовано: (2025)

Supplementary Figure S1 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
по: Carlotta Antoniotti (15352506)
Опубликовано: (2025)

Supplementary Figure S2 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
по: Carlotta Antoniotti (15352506)
Опубликовано: (2025)

Supplementary Figure S3 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
по: Carlotta Antoniotti (15352506)
Опубликовано: (2025)

Supplementary Table 9_Pro metastatic pathways identified by differential expression singlePT setting from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
по: Niccolò Roda (16437288)
Опубликовано: (2025)

Figure 1 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
по: Massimiliano Mellone (14959419)
Опубликовано: (2025)

Figure 2 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
по: Massimiliano Mellone (14959419)
Опубликовано: (2025)

Figure 3 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
по: Massimiliano Mellone (14959419)
Опубликовано: (2025)

Figure 4 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
по: Massimiliano Mellone (14959419)
Опубликовано: (2025)

Figure 5 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
по: Massimiliano Mellone (14959419)
Опубликовано: (2025)

Figure 6 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
по: Massimiliano Mellone (14959419)
Опубликовано: (2025)

Cannot write session to /tmp/vufind_sessions/sess_abq0fp2b2dbvl04bd2jitlrpik